0844 GMT - Glanbia's third-quarter double-digit volume growth in optimum nutrition and Isopure products confirms brand strength and category health, Davy Research analyst Cathal Kenny says in a research note. The Irish nutrition group posted volume figures for the business that came ahead of Davy Research's forecast, Kenny says. As a result of the EPS guidance lift to the upper end of the range, Kenny says Davy Research will likely upgrade the company's full-year EPS estimate. Shares trade 4.9% higher at 15.11 euros. (nina.kienle@wsj.com)
(END) Dow Jones Newswires
November 05, 2025 03:44 ET (08:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.